Stonepine Capital Management as of March 31, 2018
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 30 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioSpecifics Technologies | 14.0 | $26M | 590k | 44.34 | |
| Cti Biopharma | 10.8 | $20M | 5.1M | 3.90 | |
| Amarin Corporation | 9.3 | $17M | 5.8M | 3.01 | |
| Vanda Pharmaceuticals (VNDA) | 8.9 | $17M | 985k | 16.85 | |
| Apollo Endosurgery | 8.7 | $16M | 2.6M | 6.26 | |
| Viveve Med | 7.5 | $14M | 3.8M | 3.66 | |
| Cumberland Pharmaceuticals (CPIX) | 4.7 | $8.8M | 1.3M | 6.68 | |
| BioDelivery Sciences International | 4.5 | $8.3M | 3.7M | 2.25 | |
| Cardiome Pharma | 4.0 | $7.5M | 3.2M | 2.32 | |
| Noveliontherapeuti.. | 3.5 | $6.5M | 1.9M | 3.50 | |
| Alimera Sciences | 3.4 | $6.4M | 6.2M | 1.03 | |
| Dova Pharmaceuticals | 2.7 | $5.0M | 184k | 27.12 | |
| Ophthotech | 2.3 | $4.4M | 1.6M | 2.74 | |
| Veracyte (VCYT) | 2.3 | $4.3M | 774k | 5.56 | |
| Conformis | 2.2 | $4.0M | 2.8M | 1.45 | |
| Oxford Immunotec Global | 1.8 | $3.3M | 264k | 12.45 | |
| Cancer Genetics | 1.6 | $2.9M | 1.8M | 1.65 | |
| Medicrea International | 1.5 | $2.8M | 715k | 3.89 | |
| Steadymed | 1.3 | $2.3M | 721k | 3.25 | |
| Invuity | 1.1 | $2.0M | 507k | 3.85 | |
| Gemphire Therapeutics | 0.8 | $1.6M | 243k | 6.51 | |
| Sierra Oncology | 0.6 | $1.2M | 571k | 2.07 | |
| Invitae (NVTAQ) | 0.6 | $1.0M | 219k | 4.69 | |
| Zosano Pharma Corp | 0.5 | $1.0M | 200k | 5.04 | |
| Foamix Pharmaceuticals | 0.4 | $666k | 130k | 5.13 | |
| Immune Design | 0.3 | $532k | 161k | 3.30 | |
| Evolus (EOLS) | 0.3 | $535k | 59k | 9.03 | |
| Scynexis | 0.3 | $509k | 380k | 1.34 | |
| Eyenovia Inc equity | 0.2 | $365k | 40k | 9.15 | |
| Aquinox Pharmaceuticals | 0.1 | $287k | 20k | 14.09 |
